Singapore, June 6, 2023 – Pathgen, an innovative biotech startup specializing in affordable PCR-based diagnostics kits for cancer and non-communicable diseases, has been invited to pitch at the prestigious InnovFest x Elevating Founders Asia, a key event of the Asia Tech x Singapore (ATxSG) conference.
Recently recognized as one of the Top 10 Health Innovation Sprint winners in Indonesia, a national innovation competition organised by Indonesia’s Ministry of Health and East Ventures, Pathgen has been making significant strides in the healthcare industry since its inception in 2021. Their acclaimed diagnostic kits are lauded for their high compatibility, accuracy, and affordability. A streamlined data analysis process allows the Pathgen team to deliver patient results in under two hours, a remarkable achievement in the field.
The highlight of Pathgen’s presentation will be BioColomelt-Dx, their colorectal cancer diagnostic kit, which was developed in collaboration with Bio Farma, the largest pharmaceutical state-owned enterprise in Indonesia. The company will also share insights into their upcoming product, PulmoAmp-Dx, a promising innovation slated for release in the next 6-9 months.
“We are proud to represent Indonesian innovation at this prominent tech event,” said Agung Utama, Chief Business Officer of Pathgen, who will be speaking at the conference. “Our main goal here is to connect with investors and fellow founders with aligned visions and form strategic partnerships across Southeast Asia.”
The ATxSG conference, held from June 6-9, 2023, is organized by the Infocomm Media Development Authority (IMDA) and Informa Tech, and supported by the Singapore Tourism Board (STB). It offers a unique platform for conversations across business, tech, and government sectors, making it the perfect venue for Pathgen to showcase its groundbreaking diagnostic solutions.
Elevating Founders Asia is an exclusive program that connects high-potential startups with industry and investment leaders. This opportunity aligns perfectly with Pathgen’s objectives, as the company is poised for rapid growth and expansion.
As part of their forward-looking vision, Pathgen aims to continue developing and launching more products in Indonesia and Southeast Asia. This commitment to serving the region further strengthens their position as an investible and partnership-ready enterprise.
Attendees at InnovFest x Elevating Founders Asia can anticipate learning more about Pathgen’s compelling trajectory and innovative diagnostic solutions. The event promises to be a landmark occasion, not only for Pathgen but for the future of affordable and accurate diagnostics in Southeast Asia.
About Pathgen:
Pathgen is a biotech startup that provides affordable PCR-based diagnostics kits for cancer and non-communicable diseases. Based in Indonesia, Pathgen serves hospitals, clinics, and labs, both for clinical and research purposes. The company’s emphasis on affordability, high accuracy, and compatibility has led to significant recognition and success, most recently as one of the Top 10 Health Innovation Sprint winners, a national event organised by Indonesia’s Ministry of Health and East Ventures.
Contact Person:
Agung Utama
agung.utama@pathgen.co.id
+62 878 523 50203